kabutan

NANO MRNA, Net Income Forecast for the Fiscal Year Loss Widened in Downward Revision, 39% Deficit Against Net Assets

Fri Nov 14, 2025 3:30 pm JST Earnings

4571 NANO MRNA Co., Ltd. 【J-GAAP】

Earnings Report

NANO MRNA Co., Ltd. <4571> [TSE Growth] announced its financial results after the market closed on November 14th (15:30). The consolidated net loss for the cumulative second quarter of the fiscal year ending March 2026 (April to September) was a reduced loss of 0.44 billion yen (compared to a loss of 0.51 billion yen in the same period last year).

However, the full-year forecast for consolidated net income/loss has been revised downward from an expected loss of 0.86 billion yen to a loss of 1.06 billion yen (compared to a loss of 0.83 billion yen in the previous period), indicating an expansion in the loss margin The deficit amounted to a 38.7% impairment of net assets at the end of the previous fiscal year..

Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated net loss for the October to March period (second half) is expected to expand to a loss of 0.62 billion yen (compared to a loss of 0.31 billion yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the consolidated net loss improved to a deficit of 0.24 billion yen (compared to a loss of 0.36 billion yen in the same period last year). The operating profit/loss margin improved from -2628.6% in the same period last year to -617.6%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 91 -518 -471 -477 -6.8 ー Nov 10, 2023 J-GAAP
Apr - Sep, 2024 7 -373 -382 -518 -7.4 ー Nov 14, 2024 J-GAAP
Apr - Sep, 2025 41 -399 -384 -440 -6.2 ー Nov 14, 2025 J-GAAP
YoY +485.7% -7.0% -0.5% +15.1% +15.8%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance ー ー ー ー － 0 May 14, 2025 J-GAAP
Apr - Sep, 2025 Results 41 -399 -384 -440 -6.2 0 Nov 14, 2025 J-GAAP
Revision Rate － － － － －

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 75 -966 -856 -860 -12.0 0 May 14, 2025 J-GAAP
Mar, 2026 New 156 -1,060 -1,002 -1,061 -14.7 0 Nov 14, 2025 J-GAAP
Revision Rate +108.0% -9.7% -17.1% -23.4% -23.3%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 101 -382 -305 -317 -4.5 0 May 14, 2025 J-GAAP
Oct - Mar, 2025 Guidance 115 -661 -618 -621 -8.6 0 Nov 14, 2025 J-GAAP
YoY +13.9% -73.0% -102.6% -95.9% -91.8%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 135 -864 -749 -780 -11.1 0 May 14, 2024 J-GAAP
Mar, 2025 108 -755 -687 -835 -11.9 0 May 14, 2025 J-GAAP
Mar, 2026 Guidance 156 -1,060 -1,002 -1,061 -14.7 0 Nov 14, 2025 J-GAAP
YoY +44.4% -40.4% -45.9% -27.1% -24.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 7 -184 -227 -362 -5.1 -2,628.6 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 76 -112 -64 -77 -1.1 -147.4 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 25 -270 -241 -240 -3.4 -1,080.0 May 14, 2025 J-GAAP
Apr - Jun, 2025 7 -189 -200 -200 -2.9 -2,700.0 Aug 8, 2025 J-GAAP
Jul - Sep, 2025 34 -210 -184 -240 -3.4 -617.6 Nov 14, 2025 J-GAAP
YoY +385.7% -14.1% +18.9% +33.7% +34.2%

Related Articles